Top 5 Dr. Rosevear blogs of 2017
Dr. Henry Rosevear's most-read blog posts from 2017 cover topics including the AUA annual meeting, physician employment, and pain control.
Colorado urologist Henry Rosevear, MD’s blog posts remain popular with readers, and with his thoughtful, down-to-earth style of pondering and analyzing topics of interest to the practicing urologist, it’s not hard to see why. His writing also encompasses a broad range of topics, as our look at his most well-read posts from 2017 demonstrates. Here are the top five blog posts from Dr. Rosevear this year.
Burnout, biopsy, BPH, and more: Post-AUA review
Dr. Rosevear’s personal highlights from the 2017 AUA annual meeting also included a course on chemotherapy and immunotherapy as well as new guideline presentations. Read more
Do you own an S corp? Why I made the switch
Dr. Rosevear discusses the pros and cons of S corporations and explains why he decided to create one. Read more
Physician employment: Both good and bad results
The trend toward hospitals directly employing urologists to do private practice urology raises a few important questions worth exploring, writes Dr. Rosevear. Read more
The ‘post-truth’ world: How it’s drifting into medicine
"I feel that I spend more time in clinic trying to educate my patients on the misinformation they see on TV or in print than I do actually practicing medicine," laments Dr. Rosevear. Read more
Pain control: Let’s rethink our prescribing habits
In this blog post, Dr. Rosevear apologizes to those he may have hurt with prescriptions he wrote for narcotics to control pain and describes the two-step process he uses for pain control. Read more
More from Urology Times:
Top 9 peer-reviewed prostate cancer papers of 2017
Top 12 practice management articles of 2017
Top 5 malpractice articles of 2017
To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.
Real-time patient access to charts opens up real potential for misinterpretations
January 29th 2021"I have no problem with patients seeing everything in their chart. It is their medical record, after all. But I do think there should be some limitations on this access," writes Henry Rosevear, MD.
The BCG shortage: No short-term solution!
April 25th 2019"Bacillus Calmette-Guerin (BCG) intravesical immunotherapy is the most effective treatment for management of our patients with non-muscle invasive bladder cancer. What do we do without it, and how do we explain the current worldwide BCG shortage to our patients?" writes Adele M. Caruso, DNP, CRNP.
Residency vs. the real world: 5 things I wish I’d known
April 2nd 2019"Just like I’ve learned that the grass really isn’t any greener on the other side, I am learning that life in the trenches of urology, as a small-town urologist, isn't exactly what I thought it would be when I was a resident," writes Dr. Rosevear.
